Antoxis Ltd - Company Review
Antoxis Ltd - Company ReviewSummary
Antoxis Ltd (Antoxis) is a drug discovery company that develops and offers technologies for the treatments of clinical conditions such as oxidative stress and mitochondrial dysfunction. The company's kromex chemistry platform is a technology platform that addresses the deficiencies of natural redox molecules and antioxidants within a therapeutic context. Its AO-1-530 is a therapeutic compound that provides protection against oxidative stress. Antoxis develops small molecules that control cell processes, such as differentiation. The company provides products for cancer, neurodegenerative and cardiovascular conditions, and others. It concentrates on kromex compounds that show mito targeting, and potent mito-activity. The company operates through companies in commercial and academic sector. Antoxis is headquartered in Aberdeen, the UK.
This comprehensive company report of Antoxis Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.